March 22, 2018 / 12:28 PM / a month ago

BRIEF-SSY Group ‍Obtains China FDA Approvals For Drug Production For Hemofiltration Replacement Fluid

Reuters Staff

1 Min Read

March 22 (Reuters) - SSY Group Ltd:

* ‍OBTAINED APPROVALS FOR DRUG PRODUCTION AND REGISTRATION FOR HEMOFILTRATION REPLACEMENT FLUID FROM CHINA FDA Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.

0 : 0

narrow-browser-and-phone
medium-browser-and-portrait-tablet
landscape-tablet
medium-wide-browser
wide-browser-and-larger
medium-browser-and-landscape-tablet
medium-wide-browser-and-larger
above-phone
portrait-tablet-and-above
above-portrait-tablet
landscape-tablet-and-above
landscape-tablet-and-medium-wide-browser
portrait-tablet-and-below
landscape-tablet-and-below

All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.